{"id":"https://openalex.org/W4388042407","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1106","title":"1106 Molecular mechanisms of immunogenic cell death driven by PT-112","display_name":"1106 Molecular mechanisms of immunogenic cell death driven by PT-112","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388042407","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1106"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1106","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1106","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1106","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1218.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1218.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089632845","display_name":"Emma Guilbaud","orcid":"https://orcid.org/0000-0001-5261-1944","observed_orcids":["https://orcid.org/0000-0001-5261-1944","https://orcid.org/0009-0001-6116-9593"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emma Guilbaud","raw_affiliation_strings":["Weill Cornell Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070230761","display_name":"Takahiro Yamazaki","orcid":"https://orcid.org/0000-0002-7420-4394","observed_orcids":["https://orcid.org/0000-0002-7420-4394"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Takahiro Yamazaki","raw_affiliation_strings":["Weill Cornell Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Maria Congenie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Congenie","raw_affiliation_strings":["Promontory Therapeutics Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Promontory Therapeutics Inc., New York, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064024896","display_name":"Christina Y. Yim","orcid":"https://orcid.org/0009-0004-2784-1528","observed_orcids":["https://orcid.org/0009-0004-2784-1528"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina Yim","raw_affiliation_strings":["Promontory Therapeutics Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Promontory Therapeutics Inc., New York, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076162736","display_name":"Tyler David Ames","orcid":"https://orcid.org/0000-0002-1124-5236","observed_orcids":["https://orcid.org/0000-0002-1124-5236"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tyler Ames","raw_affiliation_strings":["Promontory Therapeutics Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Promontory Therapeutics Inc., New York, NY, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071827163","display_name":"Lorenzo Galluzzi","orcid":"https://orcid.org/0000-0003-2257-8500","observed_orcids":["https://orcid.org/0000-0003-2257-8500"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lorenzo Galluzzi","raw_affiliation_strings":["Weill Cornell Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I4387153466"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1218","last_page":"A1218"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.7285000085830688,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.7285000085830688,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.15780000388622284,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.08889999985694885,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunogenic-cell-death","display_name":"immunogenic cell death","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mitochondrial-dysfunction","display_name":"mitochondrial dysfunction","score":0.5550000071525574},{"id":"https://openalex.org/keywords/endoplasmic-reticulum-stress","display_name":"endoplasmic reticulum stress","score":0.7639999985694885},{"id":"https://openalex.org/keywords/integrated-stress-response","display_name":"integrated stress response","score":0.9629999995231628},{"id":"https://openalex.org/keywords/viral-mimicry","display_name":"viral mimicry","score":0.7020000219345093},{"id":"https://openalex.org/keywords/mitochondrial-dna-release","display_name":"mitochondrial DNA release","score":0.6029999852180481},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.6589999794960022},{"id":"https://openalex.org/keywords/bax","display_name":"Bax","score":0.9729999899864197},{"id":"https://openalex.org/keywords/bak1","display_name":"BAK1","score":0.9900000095367432},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.8090000152587891},{"id":"https://openalex.org/keywords/plasma-membrane-permeabilization","display_name":"plasma membrane permeabilization","score":0.8159999847412109},{"id":"https://openalex.org/keywords/calreticulin-exposure","display_name":"calreticulin exposure","score":0.7570000290870667},{"id":"https://openalex.org/keywords/hmgb1","display_name":"HMGB1","score":0.7559999823570251},{"id":"https://openalex.org/keywords/atp-release","display_name":"ATP release","score":0.5519999861717224},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6669999957084656}],"concepts":[{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.569042444229126},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5479365587234497},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5278881788253784},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.5120401978492737},{"id":"https://openalex.org/C117262875","wikidata":"https://www.wikidata.org/wiki/Q5135057","display_name":"Clonogenic assay","level":3,"score":0.5004801750183105},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4979715347290039},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.47139623761177063},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.430077463388443},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37578657269477844},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37204253673553467},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2757692337036133},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16574811935424805},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09381020069122314}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.1106","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1106","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1106","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1218.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:1ff7aeb8e41f4a2ba6dd6e552de37618","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1ff7aeb8e41f4a2ba6dd6e552de37618","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1106","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1106","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1106","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1218.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388042407.pdf","grobid_xml":"https://content.openalex.org/works/W4388042407.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W3005941398","https://openalex.org/W3046758856","https://openalex.org/W3097486180","https://openalex.org/W3167137311","https://openalex.org/W4211133027","https://openalex.org/W4281739465","https://openalex.org/W4291014886","https://openalex.org/W4307909230","https://openalex.org/W4308381993","https://openalex.org/W4324137007","https://openalex.org/W4379340085"],"related_works":["https://openalex.org/W4308381993","https://openalex.org/W4410502782","https://openalex.org/W2913491962","https://openalex.org/W4291014886","https://openalex.org/W3005941398","https://openalex.org/W6982369743","https://openalex.org/W4389228064","https://openalex.org/W4307909230","https://openalex.org/W4413111739","https://openalex.org/W7116949382"],"abstract_inverted_index":{"Background":[0],"PT-112":[1,29,60,80,159,174,212,249,284,361,393,446,475,503,531,559,594,629,651,700],"is":[2,296],"a":[3,111,195,242,343,365,376,419,561],"novel":[4,420,441,497,525],"immunogenic":[5,38,166,395,422,442,498,526,590,616,635],"small":[6],"molecule1":[7],"under":[8,380],"Phase":[9,381,414,469,491],"II":[10,382],"clinical":[11,371,383],"development":[12,384],"for":[13,385,706],"cancer":[14,27,56,72,340,386,455,540,641,684,702],"therapy.2\u20138":[15,387],"Besides":[16],"mediating":[17],"cytostatic":[18],"and":[19,25,50,115,132,142,151,189,215,267,275,292,306,357,398,545,555,634,655,677,738],"cytotoxic":[20],"effects":[21,557,680,698],"in":[22,61,92,126,164,192,208,297,318,373,404,426,451,476,508,535,568,595,638,681,749],"numerous":[23],"human":[24,114,639,682],"mouse":[26,55,89,116,405],"cells,":[28,194,214,320],"elicits":[30],"various":[31],"danger":[32],"signals":[33],"that":[34,197,723],"are":[35,312,724],"linked":[36],"to":[37,59,87,121,145,160,250,279,285,327,352,721],"cell":[39,117,396,423,443,499,527,538,591,617,636,642,703,736],"death":[40,397,424,444,500,528,592,618,637],"(ICD)":[41,501,529],"such":[42],"as":[43,46,48,186,342,364],"calreticulin":[44],"exposure,":[45],"well":[47],"ATP":[49],"HMGB1":[51],"secretion.1":[52],"9\u201311":[53],"Accordingly,":[54],"cells":[57,73,163,326,341],"succumbing":[58],"vitro":[62],"efficiently":[63],"protect":[64],"immunocompetent,":[65],"tumor-na\u00efve":[66],"mice":[67],"from":[68,560],"challenge":[69],"with":[70,82,135,171,299,321,369,375,400,478,571,597,662],"living":[71],"of":[74,105,113,149,158,203,211,222,233,248,254,283,315,324,339,345,348,378,417,440,459,474,496,512,523,558,565,577,589,603,615,673,688,699,708],"the":[75,102,147,155,201,209,220,231,246,281,288,300,322,336,346,524],"same":[76],"type.1":[77],"9":[78,96],"Moreover,":[79],"synergizes":[81,399],"PD-1":[83],"or":[84,226,237,480],"PD-L1":[85,448,505],"blockade":[86],"control":[88],"tumors":[90,574],"developing":[91],"immunologically":[93],"competent":[94],"hosts.1":[95],"This":[97,295],"work":[98],"focuses":[99],"on":[100,154,245,701],"elucidating":[101],"underlying":[103],"mechanisms":[104,314],"PT-112-induced":[106,678],"ICD.":[107],"Methods":[108],"We":[109],"harnessed":[110],"panel":[112],"lines":[118],"optionally":[119],"engineered":[120],"lack":[122,232],"specific":[123],"genes":[124],"involved":[125],"mitochondrial":[127,152,190,205,255,263,276,632,679],"apoptosis":[128,256],"(namely,":[129],"Bcl2,":[130,223,234],"Bax":[131,227,238],"Bak1)":[133],"coupled":[134],"flow":[136],"cytometry,":[137],"immunoblotting,":[138],"RT-PCR,":[139],"immunofluorescence":[140],"microscopy":[141],"clonogenic":[143],"assays":[144],"determine":[146],"impact":[148,244],"reticular":[150],"events":[153],"established":[156],"ability":[157,247,282],"kill":[161],"malignant":[162,193],"an":[165],"manner.1":[167],"Results":[168],"In":[169],"line":[170,298],"previous":[172],"findings,10\u201313":[173],"elicited":[175],"eukaryotic":[176],"translation":[177],"initiation":[178],"factor":[179],"2":[180,563,587],"subunit":[181],"alpha":[182],"(EIF2S1,":[183],"best":[184],"known":[185],"eIF2\u03b1)":[187],"phosphorylation":[188],"dysfunction":[191,277],"process":[196],"was":[198,216],"accompanied":[199],"by":[200,219,619,726],"release":[202],"interferogenic":[204],"DNA":[206,717],"(mtDNA)14":[207],"cytoplasm":[210],"treated":[213],"differentially":[217],"affected":[218],"deletion":[221],"Bax,":[224,235],"Bak1,":[225,236],"plus":[228,239,447,504,532],"Bak1.":[229],"Similarly,":[230],"Bak1":[240],"had":[241],"differential":[243,674],"elicit":[251],"early":[252],"signs":[253],"including":[257],"reactive":[258],"oxygen":[259],"species":[260],"(ROS)":[261],"generation,":[262],"transmembrane":[264],"potential":[265],"loss":[266],"ultimately":[268],"plasma":[269],"membrane":[270],"permeabilization.":[271],"Conclusions":[272],"ER":[273,304],"stress":[274,290,305,333,633,737],"appear":[278],"underlie":[280],"drive":[286],"ICD,":[287],"integrated":[289],"response,":[291],"viral":[293],"mimicry.":[294],"well-established":[301],"connections":[302],"between":[303],"cytoplasmic":[307],"nucleic":[308],"acid":[309],"sensing,":[310],"which":[311],"pristine":[313],"antiviral":[316],"defense":[317],"mammalian":[319],"capacity":[323],"dying":[325],"emit":[328],"immunostimulatory":[329],"signals.15":[330],"Whether":[331],"PT-112-driven":[332],"also":[334],"shifts":[335],"antigenic":[337],"properties":[338],"consequence":[344],"accumulation":[347],"non-mutational":[349],"neoantigens16":[350],"remains":[351],"be":[353],"determined.":[354],"Despite":[355],"these":[356],"other":[358],"open":[359],"questions,":[360],"stands":[362],"out":[363],"powerful":[366],"immunotherapeutic":[367],"agent":[368],"promising":[370],"activity":[372],"patients":[374,542,569,596],"variety":[377],"tumors1":[379],"References":[388],"Yamazaki":[389,607,692,712],"T,":[390,465,608,693,713],"et":[391,412,434,466,489,517,550,583,627,649,670,694,714,733,745],"al.":[392,413,435,467,490,518,551,584,628,650,671,695,715,734,746],"induces":[394,630],"immune":[401],"checkpoint":[402],"blockers":[403],"tumor":[406],"models.":[407],"Oncoimmunology.":[408],"2020;9(1):1721810":[409],"Karp":[410,487],"DD,":[411,488],"I":[415,470],"study":[416,439,495,522,567,588],"PT-112,":[418],"pyrophosphate-platinum":[421],"inducer,":[425],"advanced":[427,536],"solid":[428,509],"tumours.":[429,510],"EClinicalMedicine.":[430],"2022;49:101430.":[431],"Bryce":[432,581],"AH,":[433,582],"A":[436,468,519,585],"phase":[437,520,562,586],"1b":[438],"inducer":[445,502,530,593],"inhibitor":[449,506],"avelumab":[450,507,533],"metastatic":[452,598],"castrate-resistant":[453],"prostate":[454,600,640,683],"(mCRPC)":[456],"patients.":[457],"Journal":[458,576,602,687,705],"Clinical":[460,578,604],"Oncology.":[461,513,579,605],"2021;39(15_suppl):e17025-e17025.":[462],"doi:10.1200/JCO.2021.39.15_suppl.e17025":[463],"Kourelis":[464],"Dose":[471],"Escalation":[472],"Study":[473],"Patients":[477],"Relapsed":[479],"Refractory":[481],"Multiple":[482],"Myeloma.":[483],"Blood.":[484],"2020;136(Supplement":[485],"1):9\u201310.":[486],"Ib":[492],"dose":[493],"escalation":[494],"Annals":[511],"2020;31:S708.":[514],"Imbimbo":[515],"M,":[516],"IIa":[521],"(\u2018PAVE\u2019)":[534],"non-small":[537],"lung":[539],"(NSCLC)":[541],"(pts).":[543],"Immuno-Oncology":[544],"Technology.":[546],"2022;16:100237.":[547],"Swift":[548],"S,":[549],"Preliminary":[552],"efficacy,":[553],"safety,":[554],"immunomodulatory":[556],"proof":[564],"concept":[566],"(pts)":[570],"thymic":[572],"epithelial":[573],"(TETs).":[575],"2023;41(16_suppl):e20647-e20647.":[580],"castration-resistant":[599],"cancer.":[601],"2023;41(6_suppl):TPS292-TPS292.":[606],"Ames":[609],"TD,":[610],"Galluzzi":[611],"L,":[612],"Potent":[613],"induction":[614],"PT-112.":[620],"Cancer":[621,644],"Immunology":[622],"Research.":[623,645],"2019;7(2_Supplement):B199-B199.":[624],"Soler-Agesta":[625,647,668],"R,":[626,648,669],"potent":[631],"lines.":[643],"2022;82(12_Supplement):1115\u20131115.":[646],"Induces":[652],"Mitochondrial":[653,663,716],"Stress":[654],"Immunogenic":[656,735],"Cell":[657],"Death,":[658],"Targeting":[659],"Tumor":[660],"Cells":[661],"Deficiencies.":[664],"Cancers":[665],"(Basel).":[666],"2022;14(16):3851.":[667],"Characterization":[672],"metabolic":[675],"phenotypes":[676],"cells.":[685],"European":[686],"Cancer.":[689,709],"2022;174(Supplement":[690],"1):S39.":[691],"Immunologically":[696],"relevant":[697],"mitochondria.":[704],"ImmunoTherapy":[707],"2022;10(Suppl":[710],"2):A1162-A1162.":[711],"drives":[718],"abscopal":[719],"responses":[720],"radiation":[722],"inhibited":[725],"autophagy.":[727],"Nature":[728,740],"Immunology.":[729,741],"2020;21(10):1160\u20131171.":[730],"Kroemer":[731],"G,":[732],"death.":[739],"2022;23(4):487\u2013500.":[742],"Stern":[743],"LJ,":[744],"Non-mutational":[747],"neoantigens":[748],"disease.":[750],"Nat":[751],"Immunol.":[752],"2023;":[753],"IN":[754],"PRESS.":[755]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2023-11-01T00:00:00"}